Question 1

What specific symptoms of PTSD does TNX-102 SL aim to improve?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Phase 3 Study to Evaluate the Efficacy and Safety of TNX-102 SL in Participants With PTSD clinical trial (NCT03841773). Contact the study team or your healthcare provider for specific answers.

Question 2

How does this treatment compare to other options I might have?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Phase 3 Study to Evaluate the Efficacy and Safety of TNX-102 SL in Participants With PTSD clinical trial (NCT03841773). Contact the study team or your healthcare provider for specific answers.

Question 3

What are the potential side effects of TNX-102 SL?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Phase 3 Study to Evaluate the Efficacy and Safety of TNX-102 SL in Participants With PTSD clinical trial (NCT03841773). Contact the study team or your healthcare provider for specific answers.

Question 4

What does the participation process involve, and how often will I need to visit the clinic?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Phase 3 Study to Evaluate the Efficacy and Safety of TNX-102 SL in Participants With PTSD clinical trial (NCT03841773). Contact the study team or your healthcare provider for specific answers.

Question 5

Will I be able to continue my current medications while participating in this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Phase 3 Study to Evaluate the Efficacy and Safety of TNX-102 SL in Participants With PTSD clinical trial (NCT03841773). Contact the study team or your healthcare provider for specific answers.

Question 6

What happens if I experience side effects during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Phase 3 Study to Evaluate the Efficacy and Safety of TNX-102 SL in Participants With PTSD clinical trial (NCT03841773). Contact the study team or your healthcare provider for specific answers.

What this study is about